Literature DB >> 7852842

Effects of bafilomycin A1 on functional capabilities of LPS-activated alveolar macrophages.

A Bidani1, T A Heming.   

Abstract

Resident alveolar macrophages (m phi) possess plasmalemmal vacuolar-type H(+)-ATPase (V-ATPase) that plays a crucial role in regulation of intracellular pH (pHi). To assess the importance of this V-ATPase to m phi effector functions, resident alveolar m phi from rabbits were activated with E. coli-derived lipopolysaccharide (LPS) and exposed to bafilomycin A1, a specific inhibitor of V-ATPase. Bafilomycin caused a significant cytosolic acidification in both the absence and presence of CO2-HCO3-, and in both unstimulated and activated m phi. Superoxide production and Fc receptor-mediated phagocytosis also were reduced in bafilomycin-treated m phi. Similar effects were elicited by acidifying the cytoplasm in the absence of bafilomycin, by lowering extracellular pH (pHo) from 7.4 to 6.5-6.6. Thus, the effects of bafilomycin on phagocytosis and superoxide production probably were related to cytosolic acidification, secondary to blockade of V-ATPase-mediated H+ extrusion across the plasma membrane. Conversely, bafilomycin significantly increased TNF-alpha release. This effect cannot be explained by a bafilomycin-induced acidosis because acidic pHo significantly reduced TNF-alpha release. The results demonstrate that V-ATPase activity is an important determinant of the effector functions of LPS-activated m phi.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852842     DOI: 10.1002/jlb.57.2.275

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

1.  Effects of plasmalemmal V-ATPase activity on plasma membrane potential of resident alveolar macrophages.

Authors:  T A Heming; A Bidani
Journal:  Lung       Date:  2003       Impact factor: 2.584

2.  Apoptotic β-cells induce macrophage reprogramming under diabetic conditions.

Authors:  Meliza G Ward; Ge Li; Mingming Hao
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 3.  Effects of airway surface liquid pH on host defense in cystic fibrosis.

Authors:  Abigail R Berkebile; Paul B McCray
Journal:  Int J Biochem Cell Biol       Date:  2014-02-19       Impact factor: 5.085

4.  Mechanism of decreased in vitro murine macrophage cytokine release after exposure to carbon dioxide: relevance to laparoscopic surgery.

Authors:  M A West; D J Hackam; J Baker; J L Rodriguez; J Bellingham; O D Rotstein
Journal:  Ann Surg       Date:  1997-08       Impact factor: 12.969

5.  Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions.

Authors:  I M Conboy; D Manoli; V Mhaiskar; P P Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  SERS nanosensors that report pH of endocytic compartments during FcεRI transit.

Authors:  K L Nowak-Lovato; Bridget S Wilson; Kirk D Rector
Journal:  Anal Bioanal Chem       Date:  2010-09-15       Impact factor: 4.142

Review 7.  Innate host defense of the lung: effects of lung-lining fluid pH.

Authors:  Amelia W Ng; Akhil Bidani; Thomas A Heming
Journal:  Lung       Date:  2004       Impact factor: 2.584

8.  Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.

Authors:  Kristiina Rajamäki; Tommy Nordström; Katariina Nurmi; Karl E O Åkerman; Petri T Kovanen; Katariina Öörni; Kari K Eklund
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

9.  Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity.

Authors:  Lesly De Arras; Rebecca Laws; Sonia M Leach; Kyle Pontis; Jonathan H Freedman; David A Schwartz; Scott Alper
Journal:  Genetics       Date:  2013-12-20       Impact factor: 4.562

10.  Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors.

Authors:  Andras Bikov; Zsofia Lazar; Nora Gyulai; Marton Szentkereszty; Gyorgy Losonczy; Ildiko Horvath; Gabriella Galffy
Journal:  Lung       Date:  2015-08-11       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.